How AI is cutting drug discovery timelines: target identification, molecule design, toxicity prediction, and regulatory issues shaping faster therapies.
AI Accelerates Drug Discovery: Faster Paths from Lab to Patient Read More »
Sino Biological’s XpressMax cell-free kit accelerates AI-driven antibody screening by enabling rapid protein synthesis, high-throughput assays and tighter experimental loops.
How Sino Biological’s XpressMax Kit Speeds AI-Powered Antibody Discovery Read More »
NHS Shared Business Services unveils a £900m AI procurement framework (2027-2035) to buy diagnostics, analytics and robotics tech, while sparking spending debate.
NHS Launches £900M AI Healthcare Framework to Drive UK Adoption Read More »
A Nature Medicine study shows AMIE, a multimodal AI, beat primary care physicians in simulated consultations. Read strategic implications, limitations, and next steps.
How AI is improving medical imaging for earlier, more accurate diagnoses. Learn about performance gains, patient benefits, and what comes next in clinical use.
AI in Precision Diagnostics: Medical Imaging Breakthroughs Read More »
Isomorphic Labs raised $2.1 billion to scale its IsoDDE AI drug design engine. Backed by Thrive Capital, Alphabet, Temasek and the UK’s sovereign AI fund, the funding aims to speed therapeutic programs toward clinic.
Isomorphic Labs Secures $2.1B Series B to Accelerate AI Drug Discovery Read More »
Practical strategies for healthcare leaders to build patient trust in AI: transparency, strong data governance, clinician communication, patient-centered design, and human-AI collaboration.
Patient Trust: How to Drive AI Adoption in Healthcare Read More »
Tolemy Bio raised €1.4M led by Norrsken Evolve to launch Orbit, an AI-native platform that turns lab experiments into reusable intelligence for mid-sized biopharma.
Tolemy Bio Raises €1.4M to Build Orbit, an AI Control Panel for Cell Biology Read More »
Explore how Pfizer, Tempus AI and Medtronic apply artificial intelligence across drug R&D, precision medicine and medical devices to transform care.
AI in Healthcare: How Pfizer, Tempus AI and Medtronic Are Driving Change Read More »
Mayo Clinic’s radiomics AI flags pancreatic cancer up to 3 years earlier using routine CT scans. What this means for early diagnosis, barriers to rollout, and scalable solutions.
